USPTO serial 79454607
LONZA OGM
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- GARCIA, CLAUDIA
- Law office
- TMO LAW OFFICE 111
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with LONZA OGM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Consulting services for the custom manufacturing of pharmaceuticals and biologics. | ACTIVE | — |
| 042 | Pharmaceutical product development services; Pharmaceutical research and development; scientific laboratory services; scientific and technological services, namely biological research and analysis; research and research services in the field of the transfer of biological molecules into living cells, the integration of foreign nucleic acids into the genome of living cells, and transient protein expression; scientific research services for third parties in the field of biochemistry; design and development of computer hardware and software; development and research on new products for third parties; product development for third parties; product development consulting; product research and development; consulting in the field of information technology; consulting in the field of computer software; technology consulting regarding computer hardware and software systems to facilitate their selection, implementation, and use; custom engineering services for third parties in the field of chemical and biological process and plant engineering; technology services aimed at creating custom production capabilities, technologies, market selection, and portfolio composition for the life sciences and pharmaceutical industries; technology services aimed at creating scientific, technological, and digital ecosystems for third parties in the life sciences and pharmaceutical industries. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 11, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 10, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 30, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 29, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 22, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 21, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 21, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 16, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |